PharmaHub · Other Pharma & Biotech · Global

Bronchoscope Market: Market Size & Forecast 2026

The bronchoscope market encompasses diagnostic and therapeutic endoscopic devices used to examine the airways and lungs, including rigid, flexible, and single-use disposable models. Valued at approximately $2.5 billion globally in 2025, the market is expanding at a compound annual growth rate of roughly 7.4%, driven by rising respiratory disease prevalence, aging populations, and advances in minimally invasive pulmonology. Key demand forces include increasing incidence of lung cancer, chronic obstructive pulmonary disease, and infectious pulmonary conditions, alongside growing adoption of interventional bronchoscopy procedures.

Market size · 2025
$2.5 billion
CAGR · 2025–2030
7.4%
Forecast · 2030
$3.6 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $2.5bn2030 est: $3.6bn
Read the full Bronchoscope Market report →

Market Overview

The global bronchoscope market covers a range of endoscopic instruments used for diagnosing and treating conditions of the respiratory tract, including flexible fiber-optic scopes, rigid scopes, and single-use disposable models. With a 2025 market value estimated at around $2.5 billion, the sector is positioned for sustained expansion over the coming decade, supported by procedural volume growth and device upgrades across healthcare systems. Bronchoscopy serves as a critical tool in pulmonology, enabling visualization, biopsy collection, and therapeutic interventions such as airway dilation and tumor ablation.

  • Valued at approximately $2.5 billion globally in 2025
  • Includes rigid, flexible, and disposable product categories
  • Core applications span diagnostic imaging, biopsy collection, and interventional therapy

Growth Drivers

The market is primarily fueled by the rising global burden of chronic respiratory diseases, including lung cancer, COPD, asthma, and infectious pulmonary conditions, which drive procedural demand. An aging global population further amplifies the need for bronchoscopic diagnostics and interventions, as older adults face higher rates of respiratory pathology. Advances in imaging technology, such as high-definition video bronchoscopes and autofluorescence imaging, are expanding clinical utility and encouraging replacement of older equipment.

  • Rising prevalence of lung cancer and chronic respiratory diseases worldwide
  • Aging demographics increasing demand for pulmonary diagnostics and interventions
  • Technological improvements in high-definition imaging and minimally invasive techniques
Want a deeper cut on Bronchoscope Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is segmented by product type into rigid, flexible, and disposable bronchoscopes, with flexible scopes representing the largest share due to their versatility in both diagnostic and interventional procedures. End-use segmentation includes hospitals, ambulatory surgery centers, and specialty clinics, with hospitals dominating current demand. Geographically, North America and Europe hold the largest market shares, supported by advanced healthcare infrastructure and high procedural adoption rates, while Asia-Pacific is expected to register the fastest growth due to rising healthcare access and disease burden.

  • Flexible bronchoscopes lead the product segment; rigid and disposable models serve niche applications
  • Hospitals and outpatient facilities are the primary end users
  • North America and Europe lead in market share, with Asia-Pacific showing strongest growth momentum

Trends and Outlook

What are the recent trends and outlook?

The market is moving toward increased adoption of disposable and single-use bronchoscopes to address infection control concerns and reduce sterilization costs, particularly in critical care and infectious disease settings. Robotic-assisted bronchoscopy and electromagnetic navigation bronchoscopy are emerging technologies that promise improved precision in lung biopsy and nodule localization. Over the forecast period, the market is expected to maintain steady growth as healthcare systems prioritize early cancer detection and minimally invasive treatment options.

  • Growing shift toward disposable bronchoscopes driven by infection prevention and cost-efficiency
  • Robotic and navigation-enabled bronchoscopy systems gaining clinical traction
  • Continued growth projected through 2030 and beyond as lung cancer screening expands globally
Talk to a Claight analyst
Do you want to research Bronchoscope Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.